Skip to main content
. 2025 Jul 23;13(15):1783. doi: 10.3390/healthcare13151783
α4β2 nAChRs Alpha-4 beta-2 neuronal nicotinic acetylcholine receptors
BD Bipolar Disorder
BDNF Brain-Derived Neurotrophic factor
C_max Maximum Plasma Concentration
FDA Food and Drug Administration
NMDA N-methyl-D-aspartate receptors
NRT Nicotine Replacement Therapy
OR Odds Ratio
RCT Randomized Controlled Trial
SAEs Serious Adverse Events
SCZ Schizophrenia